Global Digital Polymerase Chain Reaction (PCR) Technology Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2017 – 2025
-
- Published on
-
- Published by
- Accurize Market Research
-
- Report Code:
- ACZ-8106
-
- Pages:
- 104
-
- Formate:
Global Digital Polymerase Chain Reaction (PCR) Technology Market is expected to grow at a CAGR of 12% during the forecast period 2021 to 2028.
Digital polymerase chain technology is a laboratory technique that uses a very small amount of DNA to create its specific multiple copies. This technology has an effective application in the fields such as genetic engineering, cell biology, and medical diagnostics. This procedure allows highly sensitive and accurate quantification of nucleic acids. Increasing investments in the healthcare industry and a hike in the number of infectious diseases globally are the factors driving the global digital polymerase chain technology market.
Market Dynamics
Technological advancements in the healthcare sector globally, rising genetic disorders, accuracy & efficiency, increased healthcare expenditure, fundings from the government, and upcoming R&D projects are the major reasons augmenting the growth of the global digital polymerase chain technology market. However, the high costs related to the treatment are hindering market growth.
Market Segmentation
The global digital polymerase chain technology is fragmented on the basis of Technology, Product Type, Application, End-User, and Region. Based on Technology, the global market is sub-segmented into Droplet Digital PCR, Chip Based Digital PCR and BEAMing Digital PCR. The droplet Digital PCR segment holds the largest market share owing to its preciseness and accuracy. Based on Product Type, the global market is bifurcated into Digital PCR Systems, Consumables & Reagents, and Software & Services. The Software & Services segment holds the largest market share among the Product Type segment. The Application segment covers Research, Clinical Diagnostics, and Forensics. The End-User segment holds clinical Diagnostic Laboratories, Pharmaceuticals & Biotechnology Industries, Organizations, and Universities.
Geography Analysis
Based on Region, the global digital polymerase chain technology market is segmented into North America, Europe, Asia-Pacific, and RoW. North America is further classified into U.S., Canada, and Mexico. Europe is further segmented into Germany, the U.K., France, Italy, Spain, Russia, and the rest of Europe. Asia-Pacific is segmented into China, Japan, India, Australia, South Korea, and the rest of APAC. The RoW includes South & Central America, the Middle East, and Africa. Currently, North America dominates the global digital polymerase chain technology because of the high number of patients and active market players. APAC to register the highest number of CAGR during the forecast period 2021 – 2028.
The prominent market players of the global digital polymerase chain technology market are Merck KGaA, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Qiagen N.V., Sysmex Corporation, Thermo Fisher Scientific, Inc., Stilla Technologies, 4basebio AG, Stilla Technologies, JN Medsys, and Combinati, Inc. among others.
Market Segmentation And Scope Of the Global Digital Polymerase Chain Technology Market.
· By Technology
o Droplet Digital PCR
o Chip Based Digital PCR
o BEAMing Digital PCR
· By Product Type
o Digital PCR Systems
o Consumables & Reagents
o Software & Services
· By Application
o Research
o Clinical Diagnostics
o Forensics
· By End-User
o Diagnostic Laboratories
o Pharmaceuticals & Biotechnology Industries
o Organizations
o Universities
· By Region
· North America
o US
o Canada
· Europe
o Germany
o UK
o France
o Italy
o Russia
o Spain
o Rest of Europe
· Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia Pacific
· Rest of the World
o South & Central America
o Middle East
o Africa
KEY PLAYERS
-
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- Qiagen N.V.
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Stilla Technologies
- 4basebio AG
- Stilla Technologies
- JN Medsys
- Combinati, Inc.
- Others..
Payment Options